Preview into the Diabetes Science and Technology Meeting 2024

At Monarch Medical Technologies, we are eagerly anticipating the upcoming Diabetes Science and Technology meeting from October 15-17 in Burlingame, CA. This marks the first in-person gathering in four years, and the program promises to be both engaging and informative, featuring presentations, workshops, panel discussions, and poster sessions that showcase the latest advancements in diabetes management.

Here are some key discussions that we are looking forward to:

• Continuous Glucose Monitoring (CGM): Several sessions will focus on CGM technologies, including insights from manufacturers, analytics, and innovative applications of CGM data.
• Artificial Intelligence in Diabetes Management: Explore how AI is transforming diabetes care and improving patient outcomes.
• FDA Update: Gain valuable insights from the FDA’s Office of In Vitro Diagnostics regarding regulatory developments.
• Artificial Pancreas Development: Learn about the latest strides in creating fully automated insulin delivery systems.
• Enhancing Patient Compliance: Discover how technology is being leveraged to improve adherence to diabetes management protocols.

Join us at the Poster Sessions

There will be two poster sessions, and we are excited to present our research on the safe use of the EndoTool IV insulin dosing application for patients with severe renal insufficiency. Our poster titled, Treatment of DKA in Patients with Decreased Renal Function will detail how EndoTool adapts insulin dosing based on varying degrees of renal function, underscoring the application’s commitment to patient-specific care.

We invite you to connect with our team members, including Product Manager Anderson Schrader co-author of the poster and Sales Executive Aubrey Largaespada, who will be on-site to discuss our poster and the innovative features of EndoTool Patient-Specific Insulin Dosing Software.

We look forward to an inspiring meeting and hope to see you there!